Search research articles
Contact Us
Filters
Showing results (961-970 of 988) with videos related to
Page
of 99
Sort By:
Orphanet Journal of Rare Diseases
|
January 16, 2020
Outcomes in pediatric studies of medium-chain acyl-coA dehydrogenase (MCAD) deficiency and phenylketonuria (PKU): a review
Michael Pugliese, Kylie Tingley, Andrea Chow, et al.
Pediatrics
|
July 16, 2021
Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria
Michael Pugliese, Kylie Tingley, Andrea Chow, et al.
Journal of Medicinal Chemistry
|
July 7, 2017
Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na<sub>V</sub>1.7
Nigel A Swain, Dave Batchelor, Serge Beaudoin, et al.
The Lancet. Child & Adolescent Health
|
June 12, 2026
CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trials
Ami Baba, Maureen Smith, Beth K Potter, et al.
JAMA Pediatrics
|
February 24, 2026
CONSORT-Children and Adolescents (CONSORT-C) 2026 Extension Statement: Enhancing the Reporting and Impact of Pediatric Randomized Trials
Ami Baba, Maureen Smith, Beth K Potter, et al.
JAMA Pediatrics
|
February 24, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 Extension Statement: Enhancing the Reporting and Usefulness of Pediatric Randomized Trial Protocols
Ami Baba, Maureen Smith, Beth K Potter, et al.
The Lancet. Child & Adolescent Health
|
June 12, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocols
Ami Baba, Maureen Smith, Beth K Potter, et al.
Nature Communications
|
December 15, 2015
The experimental power of FR900359 to study Gq-regulated biological processes
Ramona Schrage, Anna-Lena Schmitz, Evelyn Gaffal, et al.
BMJ (Clinical Research Ed.)
|
April 14, 2025
CONSORT 2025 statement: updated guideline for reporting randomised trials
Sally Hopewell, An-Wen Chan, Gary S Collins, et al.
Nature Medicine
|
April 14, 2025
CONSORT 2025 statement: updated guideline for reporting randomized trials
Sally Hopewell, An-Wen Chan, Gary S Collins, et al.
Page
of 99
Search research articles
Search
Showing results (961-970 of 988) with videos related to
Sort By:
Page
of 99
Orphanet Journal of Rare Diseases
|
January 16, 2020
Outcomes in pediatric studies of medium-chain acyl-coA dehydrogenase (MCAD) deficiency and phenylketonuria (PKU): a review
Michael Pugliese, Kylie Tingley, Andrea Chow, et al.
Pediatrics
|
July 16, 2021
Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria
Michael Pugliese, Kylie Tingley, Andrea Chow, et al.
Journal of Medicinal Chemistry
|
July 7, 2017
Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na<sub>V</sub>1.7
Nigel A Swain, Dave Batchelor, Serge Beaudoin, et al.
The Lancet. Child & Adolescent Health
|
June 12, 2026
CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trials
Ami Baba, Maureen Smith, Beth K Potter, et al.
JAMA Pediatrics
|
February 24, 2026
CONSORT-Children and Adolescents (CONSORT-C) 2026 Extension Statement: Enhancing the Reporting and Impact of Pediatric Randomized Trials
Ami Baba, Maureen Smith, Beth K Potter, et al.
JAMA Pediatrics
|
February 24, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 Extension Statement: Enhancing the Reporting and Usefulness of Pediatric Randomized Trial Protocols
Ami Baba, Maureen Smith, Beth K Potter, et al.
The Lancet. Child & Adolescent Health
|
June 12, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocols
Ami Baba, Maureen Smith, Beth K Potter, et al.
Nature Communications
|
December 15, 2015
The experimental power of FR900359 to study Gq-regulated biological processes
Ramona Schrage, Anna-Lena Schmitz, Evelyn Gaffal, et al.
BMJ (Clinical Research Ed.)
|
April 14, 2025
CONSORT 2025 statement: updated guideline for reporting randomised trials
Sally Hopewell, An-Wen Chan, Gary S Collins, et al.
Nature Medicine
|
April 14, 2025
CONSORT 2025 statement: updated guideline for reporting randomized trials
Sally Hopewell, An-Wen Chan, Gary S Collins, et al.
Page
of 99